|
In 1996, the City of Aurora and University of Colorado worked together to
create a special-purpose governmental entity, giving it a single mission: to imagine and govern the evolution of a historic
army medical center into one of the world’s most forward-looking bioscience districts. In partnership with the University
of Colorado and the City of Aurora, the Fitzsimons Redevelopment Authority (FRA) acquired much of the former army
site and began to implement an ambitious redevelopment plan that now comprises the growing and thriving Fitzsimons Life Science
District that includes the Colorado Science + Technology Park now adjacent to the Anschutz Medical Campus and the new V.A.
hospital campus. The FRA directs the commercial developments in the Fitzsimons
Life Science District, along with its partner, Forest City Science + Technology Group. In this role, the FRA is dedicated
to providing life science companies: an environment where they can thrive; success-enhancing resources like the District’s
incubator facilities; and services that help form connections between private industry and the University of Colorado. Aurora’s
Fitzsimons Life Science District is becoming what its founders envisioned: a functioning community that directly supports
the health and well-being of life science companies. For more information, visit: http://www.fitzscience.com. E-mail for more information
|
News Release Archive:
The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience
Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure. The new accelerator space will
be leased to existing tenants graduating from the incubator and other companies in the modest growth stage. - December 12,
2011
The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most
well-known and successful leaders in the Bioscience Industry to its Board of Directors. Change in board composition is the
result of a strategic refocus for the FRA, and those recently appointed to the board include: Donald M. Elliman, Jr.; William
Freytag, PhD; James C. T. Linfield; and David Perez. - November 15, 2011